Systemic Delivery of an mRNA-Encoding, Tumor-Activated Interleukin-12 Lock to Eliminate Tumors and Avoid Immune-Related Adverse Events

Journal:

Nano Letters

Published:

2025-09-10

DOI:

10.1021/acs.nanolett.5c03454

Affiliations:

5

Authors:

16

Go to article

Institutions	Authors	Share
Zhejiang Cancer Hospital (ZJCH), China	5.200000	0.33
Hangzhou Institute of Medicine (HIM), CAS, China	5.200000	0.33
Renji Hospital, SJTU, China	3.200000	0.20
State Key Laboratory of Chemo and Biosensing, HNU, China	1.200000	0.08
Molecular Science and Biomedicine Laboratory (MBL), HNU, China	1.200000	0.08

Interested in Oncology and Carcinogenesis?